FDA asked to detail monitoring efforts for foreign drugs.
Dow Jones Newswire (2/17, Favole) reports that Sen. Chuck Grassley (R-IA) asked the Food and Drug Administration on Tuesday for a report elaborating on their efforts to monitor foreign drugs. The agency said they have opened new offices in China, India and other regions in an effort to beef up their foreign presence, and are collaborating with foreign regulatory agencies to improve their inspection processes. Grassley said that he expected a formal response from the agency by March 2nd.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment